A miracle remedy has emerged in medical circles, being dubbed “the other ivermectin” by independent media for its potential applications in strokes, neurological damage, and heart conditions.

The compound, dimethyl sulphoxide (DMSO), was synthesized by Russian chemist Alexander Zaytsev in the late 19th century. As a byproduct of paper and wood pulp manufacturing, DMSO shields healthy cells from fatal stressors.

Due to its capacity to protect against oxidative damage, DMSO demonstrates extraordinary promise for treating heart, brain, and spinal cord ailments. It has been reported to: protect cells from death, aid circulatory disorders, serve as a promising treatment for heart attacks, function as a paradigm-shifting stroke therapy, and treat traumatic brain injuries, brain bleeds, concussions, and spinal cord injuries.

Additionally, DMSO shows potential in protein misfolding diseases including cystic fibrosis, Creutzfeldt-Jakob disease, and amyloidosis. Amyloidosis—a condition linked to certain vaccines—may be addressed by DMSO as it dissolves harmful protein aggregates.

Physician Justus R. Hope describes DMSO as “the other ivermectin,” noting his experience with it was an “awakening.” He states that the substance has faced identical treatment to ivermectin.

A Midwestern Doctor (AMD), who publishes on Substack, writes: “Words cannot begin to express my disdain over how DMSO was treated or the human cost of the callous bureaucratic dictates which have kept it from being adopted within the medical system.”

AMD spent months researching DMSO, reviewing thousands of pages of literature. He asserts that conditions deemed “untreatable” by conventional medicine could respond to DMSO. The compound has been shown to protect tissue when blood supply is cut off, prevent reperfusion injury, maintain circulatory function in critical organs including the liver, kidneys, intestines, heart, and skin, and mitigate heart damage from dietary copper deficiency as well as kidney failure caused by toxic mercury exposure.